WHO pushes two Ebola treatments found to boost survival rates - Africanews English

Publishing its first-ever guidelines on which therapeutics to use against Ebola, the UN health agency strongly recommends using two monoclonal antibodies, mAb114, also known as Ansuvimab or Ebanga, and REGN-EB3, or Inmazeb

The World Health Organization said Friday that two existing treatments dramatically reduced deaths from Ebola and should be given to people of all ages suffering from the often-fatal haemorrhagic dis… [+2548 chars]

full article...